Unlocking the Strategic Value of 867 Point of Care and DDD Data

A large pharmaceutical manufacturer with a blockbuster drug indicated for many types of cancers and generating more than $7 billion dollars in revenue,  recognized the growing strategic business value of data. After heavily investing in Master Data and System Integration (MDSI) technology, data sources and personnel, they identified gaps in syndicated DDD and 867 data.

Missing 867 data elements impacted sales operations, while missing doctor and geolocation data caused downstream problems for sales territory assignment and account planning. These data issues were compounded by the time lag of about 45 days post sale. MDSI leadership knew they had to close the gaps in 867 data and they found a solution with IntegriChain’s patient matching, national and subnational data sets and data extracts.

Download now!

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand